Please find our Security Advisories here

Publication Date: 2021 June 29 

Update Date:  2021 July 6

Philips is a committed leader in medical device cybersecurity. As part of our global Product Security Policy, the company conducts extensive, ongoing analysis of our products, often in collaboration with customers and researchers, to identify and address potential vulnerabilities.
 

In accordance with Philips’ Coordinated Vulnerability Disclosure Policy for the awareness and remediation of possible security vulnerabilities, the company is proactively issuing an advisory regarding potential issues related to the certain versions Philips Vue PACS (Picture Archiving and Communications System) software and related products:
 

• Vue PACS versions 12.2.x.x and prior
• Vue MyVue versions 12.2.x.x and prior
• Vue Speech versions 12.2.x.x and prior
•  Vue Motion versions 12.2.1.5 and prior
   

Philips has identified potential security vulnerabilities that under specific conditions could impact or potentially compromise patient confidentiality, system integrity, and/or system availability.  To minimize the potential risk of these vulnerabilities, Philips recommends that users upgrade to the latest Philips Vue PACS software running on Windows Operating System 2019 and enabling security patching procedures for timely security updates.
  

Philips’ analysis has shown that these issues require a range of low skill to high skill to exploit. In this event, unauthorized users may be able to provide unexpected input into the application, execute arbitrary code, alter the intended control flow of the
system, access sensitive information, or potentially cause a system crash.
 

Philips has identified that some of the affected vulnerabilities could be attacked remotely.  Exploits that could target some of the vulnerabilities are known to be publicly available.
 

To date, Philips has not received any reports of exploitation of these issues or of incidents from clinical use that we have been able to associate with this issue. It is unlikely that this potential vulnerability would impact clinical use. Philips released software updates and has controlling mitigations on the affected software to limit the risk and exploitability of most of these vulnerabilities.
 

Philips has reported these potential vulnerabilities and its resolution to the appropriate government agencies, including the U.S. Cybersecurity Infrastructure and Security Agency (CISA), which is issuing an advisory.

Philips also sent a letter to all its customers, user with questions regarding their specific Vue PACS solutions are advised by Philips to contact their local Philips service support team.

Cybersecurity & Infrastructure Security Agency (CISA) Advisory: https://us-cert.cisa.gov/ics/advisories/icsma-21-187-01

Publication Date: 2021 June 24 

Update Date:  2021 June 24
 

Philips is a committed leader in medical device cybersecurity. As part of our global Product Security Policy, the company conducts extensive, ongoing analysis of our products, often in collaboration with customers and researchers, to identify and address potential vulnerabilities.

In accordance with Philips’ Coordinated Vulnerability Disclosure Policy for the awareness and remediation of possible security vulnerabilities, the company is proactively issuing an advisory regarding a potential issue related to the certain versions of Philips Interoperability Solutions XDS (Software Versions 2.5 to 3.11 and 2018-1 to 2021-1).

Philips has identified a potential low-severity security vulnerability that requires a high skill level to exploit, and for which there are no known public exploits available. A highly motivated attacker can read the Lightweight Directory Access Protocol (LDAP) system credentials by gaining access to the network channel being used for communication.  Should this occur, clear text transmission of sensitive information risk applies to configurations which are configured to use LDAP via Transport Layer Security (TLS).

To minimize the potential risk of these vulnerabilities, Philips has identified the following guidance and mitigations:
 

• Administrators  should disable LDAP referrals on their LDAP servers if LDAP via TLS is used.
• Administrators should configure their LDAP servers to include a complete structure to search.
   

The Philips software is not be used for clinical use nor rated as a medical device; therefore, this potential vulnerability would not impact patient safety.
 

Philips has reported this potential vulnerability and its  mitigation to customers and the appropriate government agencies, including the U.S. Cybersecurity Infrastructure and Security Agency (CISA), which is issuing an advisory.
 

Users with questions regarding their specific Interoperability Solutions XDS installations are advised by Philips to contact their local Philips service support team. Philips contact information is available at the following location:  https://www.usa.philips.com/healthcare/solutions/customer-service-solutions or call 1-800-722-9377

Publication on Cybersecurity & Infrastructure Security Agency (CISA) website: https://us-cert.cisa.gov/ics/advisories/icsma-21-175-01

Publication Date: 2021 May 20 

Update Date: 2021 May 24

Philips is currently monitoring developments and updates related to the Federal Bureau of Investigation (FBI) (CP-000147-MW). The FBI identified at least 16 Conti ransomware attacks targeting US healthcare and first responder networks, including law enforcement agencies, emergency medical services, 9-1-1 dispatch centers, and municipalities within the last year. These healthcare and first responder networks are among the more than 400 organizations worldwide victimized by Conti, over 290 of which are located in the U.S. Like most ransomware variants, Conti typically steals victims’ files and encrypts the servers and workstations in an effort to force a ransom payment from the victim. The ransom letter instructs victims to contact the actors through an online portal to complete the transaction. If the ransom is not paid, the stolen data is sold or published to a public site controlled by the Conti actors. Ransom amounts vary widely and we assess are tailored to the victim. Recent ransom demands have been as high as $25 million. 

Conti actors gain unauthorized access to victim networks through weaponized malicious email links, attachments, or stolen Remote Desktop Protocol (RDP) credentials. Conti actors use remote access tools, which most often beacon to domestic and international virtual private server (VPS) infrastructure over ports 80, 443, 8080, and 8443. Additionally, actors may use port 53 for persistence. Large HTTPS transfers go to cloud-based data storage providers MegaNZ and pCloud servers. Other indicators of Conti activity include the appearance of new accounts and tools—particularly Sysinternals—which were not installed by the organization, as well as disabled endpoint detection and constant HTTP and domain name system (DNS) beacons, and disabled endpoint detection.

Philips is committed to ensuring the safety, security, integrity, and regulatory compliance of our products to be deployed and to operate within Philips approved product specifications. Therefore, in accordance with Philips policy and regulatory requirements, all changes of configuration or software to Philips’ products (including operating system security updates and patches) may be implemented only in accordance with Philips product-specific, verified & validated, authorized, and communicated customer procedures or field actions.

If a product does require operating system security updates, configuration changes, or other actions to be taken by our customer or by Philips Customer Services, product-specific service documentation is produced by Philips product teams and made available to Philips service delivery platforms such as the Philips InCenter Customer Portal. Once posted by Philips product teams, all of these materials are accessible to contract-entitled customers, licensed representatives, and Philips Customer Service teams.

Contract-entitled customers may use Philips InCenter and are encouraged to request Philips InCenter access and reference product-specific information posted. If customers still have questions, all customers (contract-entitled or otherwise) are encouraged to contact their local service support team or regional product service support as appropriate for up to date information specific to their Philips’ products.

Begin Update A: 24 May 2021

At this time, no Philips products or solutions are impacted. If we become aware of an affected product or solution, we will post that information here.

For customers who utilize the Remote Services Network (RSN, PRS), all Philips RSN systems are protected against this vulnerability and customers are advised not to disconnect the PRS as it may impact Philips service teams from providing any required immediate and proactive support such as remote patching.

End Update A

Publication Date: 2021 May 4

Update Date: 2021 May 4

Philips is currently monitoring developments and updates related to the Cybersecurity & Infrastructure Security Agency (CISA) advisory (AA21-110A).

CISA partners have observed active exploitation of vulnerabilities in Ivanti’s Pulse Connect Secure products. Successful exploitation of these vulnerabilities allows an unauthenticated user to perform remote arbitrary code execution on the Pulse Connect Secure gateway. Ivanti has provided a mitigation and is in the process of developing a patch.

At this time, no Philips products are impacted. If we become aware of an affected product, we will post that information here.

Publication Date: 2021 April 15

Update Date: 2021 April 30

Philips is currently monitoring developments and updates related to nine DNS vulnerabilities reported by cybersecurity researchers from Forescout and JSOF. The set of nine vulnerabilities, referred to as NAME:WRECK affect Domain Name System (DNS) implementations which affect at least four common TCP/IP stacks – FreeBSD, IPNet, NetX and Nucleus NET.

As part of the company’s product security policy and protocols, Philips’ teams are evaluating Philips’ products and solutions utilizing DNS with affected TCP/IP stacks for potential impacts from these reported vulnerabilities and validating actions.

Philips is committed to ensuring the safety, security, integrity, and regulatory compliance of our products to be deployed and to operate within Philips approved product specifications. Therefore, in accordance with Philips policy and regulatory requirements, all changes of configuration or software to Philips’ products (including operating system security updates and patches) may be implemented only in accordance with Philips product-specific, verified & validated, authorized, and communicated customer procedures or field actions.

When a product does require security updates, configuration changes, or other actions to be taken by our customer or by Philips Customer Services, product-specific service documentation will be produced by Philips product teams and made available to Philips service delivery platforms such as the Philips InCenter Customer Portal. Once posted by Philips product teams, all of these materials are accessible to contract-entitled customers, licensed representatives, and Philips Customer Service teams.

Contract-entitled customers may use Philips InCenter and are encouraged to request Philips InCenter access and reference product-specific information posted. If customers still have questions, all customers (contract-entitled or otherwise) are encouraged to contact their local service support team or regional product service support as appropriate for up to date information specific to their Philips’ products.

Begin Update A: 2021 April 30

Philips is providing the list below in order to better assist our customers in identifying any Philips’ products vulnerable to the NAME:WRECK vulnerabilities. However, the list below is not comprehensive and may be updated as necessary if more products are identified.

Publication Date: 2021 March 25 

Update Date:  2021 March 25

Philips is a committed leader in medical device cybersecurity. As part of our global Product Security Policy, the company conducts extensive, ongoing analysis of our products, often in collaboration with customers and researchers, to identify and address potential vulnerabilities.  

In accordance with Philips’ Coordinated Vulnerability Disclosure Policy for the awareness and remediation of possible security vulnerabilities, the company is proactively issuing an advisory regarding a very low-severity issue related to Philips Gemini PET/CT Family systems (CVSS v3 Score – 2.4 on a scale of 10).

This potential issue is related to storage of information in a file system or device without access control, specific to removable media. Should this issue be exploited, there is a possibility that sensitive information may be accessible by unauthorized parties. This potential vulnerability requires physical access to the removable media to exploit.

To date, Philips has not received any reports of exploitation of these issues or of incidents from clinical use that we have been able to associate with this issue.

Philips is reminding customers that users should operate all Philips deployed and supported Gemini PET/CT systems within Philips authorized specifications, including Philips approved software, software configuration, system services, and security configuration.

Customers with questions regarding their specific Philips Gemini PET/CT installations should contact their Philips support representative, visit the customer service solutions web site at https://www.usa.philips.com/healthcare/solutions/customer-service-solutions, or call 1-800-722-9377.

Publication on Cybersecurity & Infrastructure Security Agency (CISA) website: https://us-cert.cisa.gov/ics/advisories/icsma-21-084-01

Publication Date: 2021 March 10

Update Date: 2021 March 12 

Philips is currently monitoring developments and updates related to the recent F5 alert concerning four critical CVEs, along with three related CVEs (two highs and one medium).

As part of the company’s product security policy and protocols, Philips’ teams are evaluating Philips’ products and solutions utilizing F5 for potential impacts from these reported vulnerabilities and validating actions. F5 has released a patch to help remediate this vulnerability. Philips is currently in the process of validating the F5 patch and vendor recommended mitigation options. Once the F5 patch has been tested and validated by Philips with the impacted products, the patch will either be installed by Philips or made available for installation by customers, depending on contract details.

Philips is committed to ensuring the safety, security, integrity, and regulatory compliance of our products to be deployed and to operate within Philips approved product specifications. Therefore, in accordance with Philips policy and regulatory requirements, all changes of configuration or software to Philips’ products (including operating system security updates and patches) may be implemented only in accordance with Philips product-specific, verified & validated, authorized, and communicated customer procedures or field actions.

When a product does require security updates, configuration changes, or other actions to be taken by our customer or by Philips Customer Services, product-specific service documentation will be produced by Philips product teams and made available to Philips service delivery platforms such as the Philips InCenter Customer Portal. Once posted by Philips product teams, all of these materials are accessible to contract-entitled customers, licensed representatives, and Philips Customer Service teams.

Contract-entitled customers may use Philips InCenter and are encouraged to request Philips InCenter access and reference product-specific information posted. If customers still have questions, all customers (contract-entitled or otherwise) are encouraged to contact their local service support team or regional product service support as appropriate for up to date information specific to their Philips’ products.

Begin Update A: March 12, 2020

Philips is providing the list below in order to better assist our customers in identifying any Philips’ products vulnerable to CVE-2021-22986, CVE-2021-22987, CVE-2021-22991, CVE-2021-22992. However, the list below is not comprehensive and may be updated as necessary if more products are identified. It does not indicate the patch or device status.

*Software only products with customer owned Operating Systems

**Information or patch available in Incenter

***Philips hosting business is in the process of validating and deploying the patch to the managed infrastructure
 

End Update A   

Publication Date: 2021 March 8 

Update Date: 2021 March 15 

Philips is currently monitoring developments and updates related to the Cybersecurity & Infrastructure Security Agency (CISA) advisory (AA21-062A). CISA partners have observed active exploitation of vulnerabilities in Microsoft Exchange Server products. Successful exploitation of these vulnerabilities allows an unauthenticated attacker to execute arbitrary code on vulnerable Exchange Servers, enabling the attacker to gain persistent system access, as well as access to files and mailboxes on the server and to credentials stored on that system.

Successful exploitation may additionally enable the attacker to compromise trust and identity in a vulnerable network. Microsoft released out-of-band patches to address vulnerabilities in Microsoft Exchange Server. The vulnerabilities impact on-premises Microsoft Exchange Servers and are not known to impact Exchange Online or Microsoft 365 (formerly O365) cloud email services.

At this time, no Philips products are impacted. If we become aware of an affected product, we will post that information here.

Publication Date: 2021 February 24 

Update Date: 2021 March 3, 2021

Philips is currently monitoring developments and updates related to the recent exploitation of Accellion File Transfer Appliance (FTA) – AA21-055A. The joint advisory is the result of a collaborative effort by the cybersecurity authorities of Australia, New Zealand, Singapore, the United Kingdom, and the United States. Worldwide, actors have exploited the vulnerabilities to attack multiple federal and state, local, tribal, and territorial (SLTT) government organizations as well as private industry organizations including those in the medical, legal, telecommunications, finance, and energy sectors. 

According to Accellion, this activity involves attackers leveraging four vulnerabilities to target FTA customers. Accellion FTA is a file transfer application that is used to share files. In mid-December 2020, Accellion was made aware of a zero-day vulnerability in Accellion FTA and released a patch on December 23, 2020. 

Begin Update A: 2021 March 3

To date, Philips’s review has not identified products or solutions containing the Accellion file transfer vulnerabilities.

End Update A

Publication Date: 2021 February 23 

Update Date:  2021 March 15

Philips is a committed leader in medical device cybersecurity. As part of our global Product Security Policy, the company conducts extensive, ongoing analysis of our products, often in collaboration with customers and researchers, to identify and address potential vulnerabilities.  

Philips continues to review developments related to recently reported VMware ESXi and vCenter Server critically rated updates (CVE-2021-21972, CVE-2021-21973 and CVE-2021-21974), related to multiple vulnerabilities in VMware ESXi and vSphere Client (HTML5). At this time, VMWare has made software updates available to remediate these vulnerabilities in affected VMware products.

Following evaluation of the reported VMWare vulnerabilities, Philips has identified a limited number of products that contain affected VMWare software. Philips analysis has determined that the majority of these products are not affected by the reported vulnerability.

For products potentially affected by the VMWare vulnerability, Philips has determined that if affected VMWare software is updated the most recent versions containing the security upgrade, the reported vulnerabilities are mitigated. Philips does not provide or maintain VMware for customers using these products and advises customers to assess their VMware environment to determine if a software update/upgrade is necessary.

Affected Philips systems are safe for continued operation consistent with their Instructions for Use.  To date, Philips has not received any reports of exploitation of these issues or of incidents from clinical use that we have been able to associate with this issue.

Philips is committed to ensuring the safety, security, integrity, and regulatory compliance of our products to be deployed and to operate within Philips-approved product specifications.

Begin Update A: 2021 March 15

Philips is providing the list below in order to better assist our customers in identifying any Philips’ products running on VMware ESXi and vCenter that could be vulnerable to CVE-2021-21972, CVE-2021-21973 or CVE-2021-21974. However, the list below is not comprehensive and may be updated as necessary if more products are identified. It does not indicate the patch or device status.

Publication Date: 2021 February 19 

Update Date: 2021 February 19 

Philips is currently monitoring developments and updates related to the joint advisory (AA21-048A) published the results of analytic efforts between the Federal Bureau of Investigation (FBI), the Cybersecurity and Infrastructure Security Agency (CISA), and the Department of Treasury (Treasury). The report highlights the cyber threat to cryptocurrency posed by North Korea, formally known as the Democratic People’s Republic of Korea (DPRK), and provides mitigation recommendations. 

Working with U.S. government partners, FBI, CISA, and Treasury assess that Lazarus Group, which these agencies attribute to North Korean state-sponsored advanced persistent threat (APT) actors, is targeting individuals and companies, including cryptocurrency exchanges and financial service companies, through the dissemination of cryptocurrency trading applications that have been modified to include malware that facilitates theft of cryptocurrency.

The US Government has identified malware and indicators of compromise (IOCs) used by the North Korean government to facilitate cryptocurrency thefts; the cybersecurity community refers to this activity as “AppleJeus.”

At this time, no Philips products are impacted. If we become aware of an affected product, we will post that information here.

Begin Update C: 2021 March 23

Publication Date: 2021 January 14 

Update Date:  2021 January 14

Philips is a committed leader in medical device cybersecurity. As part of our global Product Security Policy, the company conducts extensive, ongoing analysis of our products, often in collaboration with customers and researchers, to identify and address potential vulnerabilities.

In accordance with Philips’ Coordinated Vulnerability Disclosure Policy for the awareness and remediation of possible security vulnerabilities, the company is proactively issuing an advisory regarding software versions of Philips Interventional WorkSpot, Coronary Tools/Dynamic Coronary Roadmap/Stentboost Live, and ViewForum running on older Haswell workstations.

Philips has become aware of a potential moderate-severity security vulnerability in affected systems. This potential vulnerability requires access to the hospital network to exploit. Should successful exploitation occur, there is a possibility that an attacker already within the hospital network could potentially shut down or restart the workstation.

In the event that the workstation is remotely shut down, physicians are still able to use diagnostic imaging from the X-ray system. To date, Philips has not received any reports of exploitation of these issues or of incidents from clinical use that we have been able to associate with this issue.

Philips has released a software patch to proactively address this vulnerability in the installed base, and will schedule service activities with impacted customers to implement the correction. As a mitigation for this potential security vulnerability, customers with expertise are advised to change the IPMI password for the workstation interface.

Customers with questions regarding their specific Philips Interventional WorkSpot, Coronary Tools/Dynamic Coronary Roadmap/Stentboost Live, and ViewForum installations should contact their Philips support representative or call 1-800-722-9377 with reference to field change order (FCO) number FCO72200452.

Please see the Philips product security web site for the latest security information for Philips products: https://www.philips.com/productsecurity

Cybersecurity & Infrastructure Security Agency (CISA) Advisory: https://us-cert.cisa.gov/ics/advisories/icsma-21-019-01

ADDENDUM: Affected Product List

This issue affects four Haswell workstations labeled with 12NC identification numbers [4598 009 39471, 4598 009 39481, 4598 009 70861, 4598 009 98531] when running the following versions of interventional software:

• Interventional Workspot [Release 1.3.2, 1.4.0, 1.4.1, 1.4.3, 1.4.5]
• Coronary Tools/Dynamic Coronary Roadmap/Stentboost Live [Release 1.0]
• ViewForum [Release 6.3V1L10]